Blog: Apr 2019

Source Multiple Sclerosis News Today: T20K, Cyxone‘s lead compound for treating multiple sclerosis (MS), seems able to prevent or slow disease progression, according to data from preclinical studies. Based on these findings, the company is confident that T20K might become a prophylactic (preventive) medication for MS in the near future.

Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS).

Source BBC: Lifts and adjustable ticket counters will be among the new measures brought in over the next five years.

The changes, part of an "inclusive transport strategy", will help disabled passengers as well as those travelling with children or luggage. Liverpool Central and Luton in England, Barry Town in Wales, and Dumfries in Scotland are among the stations chosen.

The Department for Transport says the sites were selected based on criteria which included their usage,...

Source MS Society: Small but mighty, mitochondria provide the energy that busy nerve cells need to survive.

We spoke with mitochondria expert Dr Don Mahad, from the University of Edinburgh, about what makes them so special - and what goes wrong in MS.

Mitochondria and progressive MS

‘I’m interested in energy production and demand in the brain and spinal cord, and especially how this changes in progressive MS.’ It’s the mitochondria that generate the bulk of this...